
Alpha Profiles · Company Profile
Q32 Bio Inc.
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory…
https://registry.alpha.ac/companies/q32-bio-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: QTTB
- Verification
- Partially verified
- Last reviewed
- 2026-09-25T04:46:57.767937+00:00
Overview
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation.
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-09-25T04:46:57.767937+00:00
